期刊文献+

血清降钙素原、D-二聚体联合检测在门诊治疗社区获得性肺炎中的应用 被引量:3

The Clinical Significance of Combined Detection with Procalcitonin and D-dimer in Serum in Treating Community-acquired Pneumonia at Outpatient Department
暂未订购
导出
摘要 目的探讨血清降钙素原(PCT)、D-二聚体联合检测在门诊治疗社区获得性肺炎(community-acquiredpneumonia,CAP)中的应用价值。方法收集2009年6月~2011年11月在门诊接受治疗的CAP患者32例,另随机抽取30例健康体检者为对照组,治疗前及第8天清晨采集静脉血检测PCT及D-二聚体,同时进行PSI评分并分组,其中PSI I级12例,PSIⅡ级12例,PSIⅢ级8例,并对各组PCT及D-二聚体的检测结果进行比较。结果CAP组血清PCT及D-二聚体水平明显高于对照组(P<0.01),CAP组治疗后PCT及D-二聚体水平明显低于治疗前(P<0.01);CAP患者PSI分组中,各组PCT、D-二聚体水平明显高于对照组,差异有统计学意义(P<0.01,P<0.05),PSIⅢ级组高于PSIⅠ级组及Ⅱ级组(P<0.01,P<0.05)。结论血清PCT与D-二聚体对CAP有诊断意义,与CAP的严重程度有一定的相关性。因此检测二者血清水平可以帮助临床医师早期诊断CAP,为正确判断病情,合理治疗提供参考依据。 Objective To investigate the clinical significance of combined detection with procalci- tonin and D-dimer in serum in treating community-acquired pneumonia(CAP)at outpatient de- partment. Methods The serum of 32 patients with community-acquired pneumonia treated at the outpatient department was collected, and the serum of 30 healthy people was randomly collected as the control group. Before treatment and in the early morning of eighth day, venous blood was collected to test PCI and D-dimmer. At the same time, PSI score was calculated and classified. Results The levels of procalcitonin and D- dimer in serum of CAP group had sta- tistical difference compared with the healthy group (P〈0.01). The levels of procalcitonin and D -dimer in serum of CAP group before therapy had statistical difference compared with that af- ter therapy, (P〈0.01). Conclusion Serum PCT and D-dimer has significant value in diagnosis, and is related to the severity of CAP. So the detection of procalcitonin and D-dimer may help the clinician with early diagnosis of CAP in that it can provide reference for the evaluation of severity of illness and rational therapy.
出处 《湖北民族学院学报(医学版)》 2012年第4期20-22,共3页 Journal of Hubei Minzu University(Medical Edition)
关键词 社区获得性肺炎 降钙素原 D-二聚体 community-acquired pneumonia procalcitonin D-dimer
  • 相关文献

参考文献9

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3113
  • 2Bellmann-Weiler R, Ausserwinkler M, Kurz K, et al. Clin- ical potential of C-Reactive Protein and Procalcitonin ser- um concentrations to guide differential diagnosis and clini- cal management of pneumococcal and legionella pneumo- nia[ J ]. J Clin Microbio1,2010 ,48 (5) :1915-1917.
  • 3Kanwar M, Brar N, Khatib R, et al. Misdiagnosis of com- munity-acquired pneumonia and inappropriate utilization of antibiotics; side effects of the 4-h antibiotic adminis- tration rule [ J ]. Chest,2007,131 : 1865-1869.
  • 4Beeker KL, Snider R, Nylen ES. Proealeition assay in sys- temic inflammation, infection, and sepsis : clinical utility and limitations [ J ]. Crit Care Med, 2008,36 ( 3 ) :941- 952.
  • 5杨慧,王镇山.血清降钙素原的生化特性及在呼吸道感染中的应用[J].大连医科大学学报,2008,30(1):80-83. 被引量:10
  • 6Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:cluster- randomised, single-blinded intervention trim [ J ]. Lacet, 2004,363 (9409) :600-607.
  • 7Masia M, Guti arez F, Shum C, et al. Usefulness of procal- citonin levels in community-acquired pneumonia accord- ing to the patients outcome research team pneumonia se- verity index[ J]. Chest,2005,128 (4) :2223-2229.
  • 8Muller F, Christ- Crain M, Breqenzer T, et al. Procalcito- nin levels predict bacteremia in patients with community- acquired pneumonia: a prospective cohort trial [ J ]. Chest ,2010,138 ( 1 ) : 121-129.
  • 9Chalmers JD, Singanayagam A, Scally C, et al. Admission D-dimer can identify low-risk patients with community- acquired pneumonia[ J ]. Ann Emerg Med, 2009,53 ( 5 ) : 633-638.

二级参考文献45

共引文献3121

同被引文献32

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部